These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 4171706)

  • 21. Hyperthyroidism and pregnancy.
    Reinfrank RF
    J Reprod Med; 1972 Feb; 8(2):56-8. PubMed ID: 4125756
    [No Abstract]   [Full Text] [Related]  

  • 22. [Thyrotoxicosis].
    Nagata I
    Naika Hokan; 1970 Dec; 17(12):459-77. PubMed ID: 4099951
    [No Abstract]   [Full Text] [Related]  

  • 23. [Addison's disease and thyrotoxic crisis].
    Couturier E; Vanhaelst L; Copinschi G; Bonnyns M; Bastenie PA
    Presse Med (1893); 1969 Mar; 77(14):515-6. PubMed ID: 4181927
    [No Abstract]   [Full Text] [Related]  

  • 24. The pathogenesis of thyrotoxicosis the discovery of LATS.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
    Friis T
    Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
    [No Abstract]   [Full Text] [Related]  

  • 26. The long-acting thyroid stimulator and the result of I 131 treatment for thyrotoxicosis.
    Martin FI; Larkins RG; Alford FP; Andrews JT; Greenberg PB; Melick RA; Penington JS
    Aust N Z J Med; 1972 May; 2(2):168-72. PubMed ID: 4116447
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical significance of LATS and TSH in the blood.
    Lemarchand-Béraud T; Griessen M; Scazziga BR
    Ann Clin Res; 1972 Jun; 4(3):121-37. PubMed ID: 4625026
    [No Abstract]   [Full Text] [Related]  

  • 28. Neutralization of "long-acting thyroid stimulator" of Graves' disease by antisera to bovine pituitary thyrotropin.
    WERNER SC; TIERNEY J
    Proc Soc Exp Biol Med; 1961 Dec; 108():780-4. PubMed ID: 14006235
    [No Abstract]   [Full Text] [Related]  

  • 29. [Etiology of Basedow's disease, with special reference to LATS].
    Nagata K
    Naika Hokan; 1969 Jul; 16(7):297-317. PubMed ID: 4901097
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on the mechanism of the inhibitory action of excess iodide on the release of radioiodine from the rat thyroid gland.
    Yamada T; Lewis AE
    Endocrinology; 1968 Jan; 82(1):54-61. PubMed ID: 4169406
    [No Abstract]   [Full Text] [Related]  

  • 31. [L.A.T.S. activity during hyperthyroidism. Apropos of 143 cases of Basedow's disease].
    Letonturier P; Tourneur R; Sénécal P
    Ann Med Interne (Paris); 1974 May; 125(5):463-7. PubMed ID: 4140703
    [No Abstract]   [Full Text] [Related]  

  • 32. EVIDENCE OF A NORMALLY FUNCTIONING PITUITARY TSH SECRETION MECHANISM IN A PATIENT WITH A HIGH BLOOD LEVEL OF LONG-ACTING THYROID STIMULATOR.
    ADAMS DD; KENNEDY TH
    J Clin Endocrinol Metab; 1965 May; 25():571-6. PubMed ID: 14313750
    [No Abstract]   [Full Text] [Related]  

  • 33. Radioimmunological studies on the long-acting thyroid stimulator.
    Pinchera A; Rovis L; Grasso L; Liberti P; Martino E; Fenzi GF; Baschieri L
    Endocrinology; 1970 Aug; 87(2):217-25. PubMed ID: 4193237
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ophthalmologic changes in hyperthyroidism].
    Hagert M
    Z Gesamte Inn Med; 1971 Aug; 26(16):501-8. PubMed ID: 4110417
    [No Abstract]   [Full Text] [Related]  

  • 35. [Characterization of the long-acting thyroid stimulator. Considerations on preliminary results].
    Tourneur R; Letonturier P; Sénécal P
    MMW Munch Med Wochenschr; 1974 Mar; 116(13):677-9. PubMed ID: 4212576
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies.
    Pinchera A; Liberti P; Martino E; Fenzi GF; Grasso L; Rovis L; Baschieri L; Doria G
    J Clin Endocrinol Metab; 1969 Feb; 29(2):231-8. PubMed ID: 4179303
    [No Abstract]   [Full Text] [Related]  

  • 37. [Exploration of thyroid-stimulating hormone (TSH) secretion].
    Ketelslegers JM; Jakubowski HD; Franchimont P
    Rev Fr Endocrinol Clin; 1970; 11(2):133-41. PubMed ID: 4098225
    [No Abstract]   [Full Text] [Related]  

  • 38. CLINICAL STUDIES ON THE LONG-ACTING THYROID STIMULATOR.
    NOGUCHI A; KURIHARA H; SATO S
    J Clin Endocrinol Metab; 1964 Feb; 24():160-5. PubMed ID: 14123839
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the increase of urinary radioactivity after administration of tapazole in subjects pretreated with radioiodine. I. Behavior in hyperthyroidism and in simple sporadic goiter].
    Minozzi M; Faggiano M; Nunziata V; Bianco A
    Folia Endocrinol; 1966 Aug; 19(4):452-63. PubMed ID: 4170448
    [No Abstract]   [Full Text] [Related]  

  • 40. The nature and significance of the long-acting thyroid stimulator.
    Kriss J
    Adv Metab Disord; 1968; 3():209-30. PubMed ID: 4178338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.